Portugal - Healthcare, Regulatory and Reimbursement Landscape

Portugal - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report, Portugal - Healthcare, Regulatory and Reimbursement Landscape. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Portugal. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

The Portuguese pharmaceutical market was valued at 2.61B in 2012, which increased to 2.81 in 2020 at a Compound Annual Growth Rate (CAGR) of 0.90%. It is forecast to reach 2.91B in 2025 at 1.0% CAGR. In terms of US dollars, it was valued at $3.36B in 2012, which decreased at a negative CAGR of 0.57% to $3.21B in 2020. The market value is expected to decrease further to $3.12B by 2025. This difference is due to currency exchange fluctuations. The medical devices market in Portugal was worth $1.10B in 2015, which increased at a CAGR of 4.68% to $1.38B in 2020. It is expected to grow at a CAGR of 3.13% from 2020 to reach $1.61B in 2025. Portugal is a hybrid of public and private sectors, offering excellent healthcare services with universal coverage, innovative healthcare infrastructure, and new emerging technologies.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Portugal, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Merck, AstraZeneca, Sanofi, and Teva Pharmaceuticals
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Stryker, Olympus, and Smith & Nephew
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the countrys healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Portuguese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Portugueses healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Portugueses healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

2 Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Portugal Healthcare Market
2.3 Key Highlights: Healthcare Startups in Portugal
2.4 Key Events: Portugal Healthcare Industry, 2015-2021
2.5 Key Events: Portugal Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Portugal, 2020
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Portugal
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Portugal
3.7 COVID-19 Epidemiology, Portugal
3.8 COVID-19 Impact and Developments in the Healthcare Market, Portugal
3.9 COVID-19 Clinical Trials Landscape, Portugal
3.10 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5 Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Portugal, 2019-2021
6.2 Deal Analysis: Medical Device Market, Portugal, 2019-2021
7 HealthTech Landscape
7.1 HealthTech Landscape, Portugal
7.2 Adoption of Technology in Healthcare, Portugal
7.3 HealthTech Deals Landscape, Portugal
7.4 Key HealthTech Deals, Portugal
7.5 Regulatory Scenario Covering Use of Technology in Healthcare, Portugal
7.6 HealthTech Landscape: Benefits and Risks, Portugal
8 Market Access
8.1 Overview of Healthcare System, Portugal
8.2 Reimbursement Process, Portugal
8.3 Overview of Insurance Providers, Portugal
8.4 Healthcare Spending and Consumer Price Index, Portugal
8.5 Pricing Policies, Portugal
8.6 Regulatory Landscape, Portugal
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, EU
8.6.3 Market Authorization for Pharmaceutical Products (National Procedure), Portugal
8.6.4 Market Authorization for Pharmaceutical Products (Centralized Procedure), Portugal
8.6.5 Marketing Authorization for Pharmaceutical Products (Decentralized Procedure), Portugal
8.6.6 Marketing Authorization for Pharmaceutical Products (Mutual Recognition Procedure), Portugal
8.6.7 Marketing Authorization for Medical Devices, Portugal
8.6.8 Intellectual Property Rights, Patent, Portugal
8.6.9 Intellectual Property Rights, European Patent, Portugal
8.6.10 Intellectual Property Rights, Unitary Patent, Portugal
8.6.11 Intellectual Property Rights, Trademark, Portugal
8.6.12 Clinical Trial Regulation, Portugal
8.6.13 Pharmaceutical Clinical Trials Landscape, Portugal
8.6.14 Medical Devices Clinical Trials Landscape, Portugal
8.6.15 Pharmaceutical Export and Import, Portugal
8.6.16 Pharmacy Regulations, Portugal
8.6.17 Pharmaceutical Advertisement Regulations, Portugal
8.6.18 Labeling and Packaging Regulations, Portugal
9 Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Portugal
9.2 Healthcare Facilities, Portugal
9.3 Healthcare Parameters, Portugal
9.4 Life Expectancy and Immunization Rate, Portugal
9.5 Environmental Health, Portugal
9.6 Healthcare Personnel, Portugal
9.7 Disease Burden, Portugal
9.8 Healthcare Expenditure, Portugal
10 Trade Associations, Portugal
11 Trade Fairs, Portugal
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List Of Tables

Table 1: COVID-19 Indicators (Number of Cases), Portugal and Global, 2020-2021
Table 2: Warning Levels and the Portuguese Response to the COVID-19 Crisis, 2020
Table 3: Authorized COVID-19 Vaccines, Portugal, 2020-2021
Table 4: Medical Devices Market, Portugal, Major Segments ($M), 2020
Table 5: Hospital Supplies Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 6: Cardiovascular Devices Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 7: General Surgery Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 8: Diabetes Care Devices Market, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 9: Orthopedic Devices, Portugal, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Patent Fees, Portugal, 2020
Table 11: Trademark Fees, Portugal, 2021
Table 12: Clinical Trial Process Fees, Portugal, 2020
Table 13: Trade Fairs, Portugal

List Of Figures

Figure 1: Pharmaceutical Market, Portugal, Revenue ($B and B), 2012-2020
Figure 2: Medical Devices Market, Portugal, Revenue ($B), 2015-2020
Figure 3: Healthcare Start-Ups in Portugal, 2020
Figure 4: Country Profile, Portugal, 2020
Figure 5: Pharmaceutical Market, Portugal, Revenue ($B), 2012-2020
Figure 6: Pharmaceutical Market, Portugal, Revenue Forecast ($B), 2021-2025
Figure 7: Pharmaceutical Exports ($B), Portugal, 2012-2020
Figure 8: Top Export Partners, Portugal, 2020
Figure 9: Pharmaceutical Imports ($B), Portugal, 2012-2020
Figure 10: Top Import Partners, Portugal, 2020
Figure 11: Pharmaceutical Market, Supply Channel, Portugal, 2021
Figure 12: Generic Drugs Usage (Share by Volume), Portugal, 2012-2020
Figure 13: Generic Drugs Usage (Share by Value), Portugal, 2012-2020
Figure 14: OTC Medicines Market, Major Categories ($M), Portugal, 2020
Figure 15: OTC Medicines Market, Revenue ($M), Portugal, 2012-2020
Figure 16: OTC Medicines Market, Major Distribution Channels ($M), Portugal, 2020
Figure 17: Total Drug Expenditure by Therapeutic Class ($M), Portugal, 2020
Figure 18: Major Therapeutic Areas by Pharmaceutical Sales ($M), Portugal, 2018-2020
Figure 19: COVID-19, Number of Confirmed Cases, Portugal, 2020-2021
Figure 20: COVID-19, Number of Deaths, Portugal, 2020-2021
Figure 21: COVID-19-Related Travel Restrictions, Portugal, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Timeline, Portugal, 2020-2021
Figure 23: Vaccine Doses Administered per 1,000 People, Portugal, 2021
Figure 24: COVID-19 Clinical Trials Count by Trial Status, Portugal, 2020-2021
Figure 25: COVID-19 Clinical Trials Count by Phase, Portugal, 2020-2021
Figure 26: COVID-19 Clinical Trials Sponsors by Trial Count, Portugal, 2020-2021
Figure 27: Top COVID-19 Marketed Products by Category (Number of Available Marketed Products), Portugal
Figure 28: Top COVID-19 IVD Products by Equipment Type (Number of Available Marketed Products), Portugal
Figure 29: Top COVID-19 Marketed Products by Product Class (Number of Available Marketed Products), Portugal
Figure 30: Top Five Company/University Name by Count, Portugal
Figure 31: Medical Devices Market, Portugal, Revenue ($B), 2015-2020
Figure 32: Medical Devices Market, Portugal, Revenue Forecast ($B), 2021-2025
Figure 33: Medical Devices Market, Portugal, Major Segments (%), 2020
Figure 34: Hospital Supplies Market, Portugal, Revenue ($M), 2017-2025
Figure 35: Hospital Supplies Market, Portugal, Market Share of Major Players (%), 2020
Figure 36: Cardiovascular Devices Market, Portugal, Revenue ($M), 2017-2025
Figure 37: Cardiovascular Devices Market, Portugal, Market Share of Major Players (%), 2020
Figure 38: General Surgery Market, Portugal, Revenue ($M), 2017-2025
Figure 39: General Surgery Market, Portugal, Market Share of Major Players (%), 2020
Figure 40: Diabetes Care Devices Market, Portugal, Revenue ($M), 2017-2025
Figure 41: Diabetes Care Devices Market, Portugal, Market Share of Major Players (%), 2020
Figure 42: Orthopedic Devices Market, Portugal, Revenue ($M), 2017-2025
Figure 43: Orthopedic Devices Market, Portugal, Market Share of Major Players (%), 2020
Figure 44: Diagnostics Market, Portugal, Revenue ($M), 2015-2020
Figure 45: Diagnostics Market, Portugal, Revenue Forecast ($M), 2021-2025
Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Portugal, 2019-2021
Figure 47: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Portugal, 2019-2021
Figure 48: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Portugal, 2019-2021
Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Portugal, 2019-2021
Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Portugal, 2019-2021
Figure 51: M&A Deals by Quarter, Pharmaceutical Market, Portugal, 2019-2021 (by value and by number)
Figure 52: Deal Value and Deal Count, Medical Devices Market, Portugal, 2019-2021
Figure 53: Deal Value and Deal Count Sub-types, Medical Devices Market, Portugal, 2019-2021
Figure 54: Deal Value and Deal Count, Quarterly, Medical Devices Market, Portugal, 2019-2021
Figure 55: Top Equipment Sectors by Deal Value, Medical Devices Market, Portugal, 2019-2021
Figure 56: Top Equipment Sectors by Deal Count, Medical Devices Market, Portugal, 2019-2021
Figure 57: M&A Deals by Equipment Sector, Medical Devices Market, Portugal, 2019-2021 (by value and by number)
Figure 58: VC Deals by Quarter, Medical Devices Market, Portugal, 2019-2021 (by value and by number)
Figure 59: Methodology Adopted for the Elaboration of PENTS, Portugal
Figure 60: TeleHealth Timeline in Portugal
Figure 61: Objectives of AI Portugal 2030
Figure 62: Interacting Processes of AI Portugal 2030
Figure 63: Areas of specialization in Portugal
Figure 64: Adoption of Technology in Healthcare, Portugal
Figure 65: Deal Value ($M), HealthTech, Portugal, 2019-2021
Figure 66: Deal Count (Number of Deals), HealthTech, Portugal, 2019-2021
Figure 67: GDPR Compliance Checklist, EU, 2021
Figure 68: Overview of Healthcare System, Portugal, 2020
Figure 69: Key Areas Covered by SiNATS
Figure 70: Overview of Financial Flow, Portugal, 2020
Figure 71: Drug Reimbursement Process, Portugal
Figure 72: OOP Expenditure (% of HealthSpending), Portugal, 2012-2019
Figure 73: Annual Average Rate of Change (%), Consumer Price Index, Healthcare Products, Portugal, 2012-2020
Figure 74: INFARMED Organizational Structure, Portugal, 2020
Figure 75: Marketing Authorization for Pharmaceutical Products, EU, 2020

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available